Home > Products > CD30 & CD64
> Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG(L)-scFv)
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-110)
Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-CD30 antibody are fused to the C terminus of an anti-CD64 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget neutrophilscells to tumor cells. It is designed for the research of Neuroblastoma; Osteosarcoma; Hodgkin lymphoma; T cell lymphoma; Anaplastic large cell lymphoma (ALCL) therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD30 x Anti-CD64 Bispecific Antibody (IgG(L)-scFv) (IGLFV-110). Click the button below to contact us or submit your feedback about this product.